Babson Diagnostics
Private Company
Total funding raised: $44.7M
Overview
Babson Diagnostics is a private, pre-revenue company developing a novel platform for convenient, capillary-based blood collection and diagnostic testing. Founded in 2017 and based in Austin, Texas, the company's technology is designed to enable high-quality, FDA-cleared blood tests using a small sample from a fingerstick, performed by retail pharmacy staff. This approach targets the significant market for routine health monitoring, aiming to reduce barriers to testing and improve preventative care. Babson is positioned as a diagnostics service provider, building a network of accessible testing locations.
Technology Platform
Integrated system for convenient, standardized capillary blood collection, sample stabilization, and laboratory analysis designed for use in retail settings.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competition includes large national laboratories (Quest, LabCorp) with their own retail draw sites and at-home kits, other startups targeting convenient blood collection, and direct-to-consumer testing companies. Babson's differentiation is its focus on integrating a standardized, high-quality service into existing retail pharmacy workflows.